CETPi Forum

Cholesteryl Ester Transfer Protein (CETP)

• Cholesteryl ester transfer protein (CETP) is a major player in the transport of cholesterol in plasma
• CETP promotes the transfer of cholesterol from HDL to LDL. Inhibition of CETP therefore has the potential to shift this in favour of protective HDL
• In this exciting area of research, key clinical studies are investigating whether CETP inhibition (CETPi) is a new approach to lower the risk of atherosclerosis and its consequences. These results are eagerly awaited by researchers and clinicians

About CETPi Forum

• The only independent source of news and expert analysis specifically focused on CETP modulation
• Peer-reviewed and open access
• Resources include downloadable powerpoint presentations and continuing education programmes
• Updated weekly

What's New

• CETP inhibition improves postprandial HDL2 functionality
• Persistence of anacetrapib lipid effects post- therapy
• News for evacetrapib, a novel CETP inhibitor
• ESC Congress 2011: Satellite Report: In focus, cardiovascular risk, high-density lipoprotein and the role of CETP
• New from ILLUMINATE: CETP inhibition improves glycaemic control

Expert Opinion

Discussion of critical clinical and scientific questions by key opinion leaders

Question of the month
Outcomes studies with CETP inhibitors - hypothetical discussions

Professor Philip Barter, HDL Forum Editor and Director of The Heart Research Institute, Sydney Australia